ChronoScale Corporation Common Stock (NASDAQ:CHRN) Short Interest Update

ChronoScale Corporation Common Stock (NASDAQ:CHRN) was the target of a large growth in short interest in May. As of May 15th, there was short interest totaling 424,399 shares, a growth of 135.1% from the April 30th total of 180,534 shares. Approximately 12.8% of the company’s stock are short sold. Based on an average daily volume of 420,857 shares, the days-to-cover ratio is currently 1.0 days.

Institutional Trading of ChronoScale Corporation Common Stock

Large investors have recently added to or reduced their stakes in the company. Roble Belko & Company Inc grew its holdings in shares of ChronoScale Corporation Common Stock by 104.5% in the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock worth $25,000 after purchasing an additional 1,195 shares during the last quarter. Virtu Financial LLC bought a new position in ChronoScale Corporation Common Stock during the 3rd quarter worth about $57,000. Shay Capital LLC purchased a new position in ChronoScale Corporation Common Stock during the 3rd quarter valued at about $67,000. Citadel Advisors LLC purchased a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter worth approximately $198,000. Finally, Geode Capital Management LLC boosted its stake in shares of ChronoScale Corporation Common Stock by 68.9% during the fourth quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after purchasing an additional 10,281 shares in the last quarter. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Trading Down 7.6%

NASDAQ:CHRN traded down $1.39 during midday trading on Tuesday, reaching $16.97. 260,428 shares of the stock traded hands, compared to its average volume of 384,741. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.03 and a current ratio of 1.55. The company has a fifty day moving average of $12.47 and a 200 day moving average of $9.50. The stock has a market capitalization of $60.46 million, a P/E ratio of -3.15 and a beta of 0.86. ChronoScale Corporation Common Stock has a 12 month low of $2.73 and a 12 month high of $20.70.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings results on Tuesday, April 28th. The company reported ($2.04) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($2.01). ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The company had revenue of $2.14 million during the quarter, compared to the consensus estimate of $4.29 million. On average, research analysts predict that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of ChronoScale Corporation Common Stock in a research report on Friday, March 27th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $6.00.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.